ShanXi C&Y Pharmaceutical Group Co.,LTD. (SHE:300254)
China flag China · Delayed Price · Currency is CNY
9.31
-0.31 (-3.22%)
Jun 11, 2026, 3:04 PM CST

SHE:300254 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash & Equivalents
137.61161.32149.52132263.95107.26
Cash & Short-Term Investments
137.61161.32149.52132263.95107.26
Cash Growth
58.14%7.89%13.27%-49.99%146.09%-43.08%
Accounts Receivable
222.17263.75176.7119.5107.67132.18
Other Receivables
21.741917.6213.588.4410.58
Receivables
243.91282.74194.32133.09116.11142.76
Inventory
149.15132.91132.79120.83103.26108.38
Prepaid Expenses
--2.492.49--
Other Current Assets
32.9827.0821.7518.1424.7217.49
Total Current Assets
563.64604.06500.87406.55508.03375.89
Property, Plant & Equipment
283.19295.97306.56297.52356.42386.14
Long-Term Investments
102.16102.6101.19101.7286.0390.92
Goodwill
311.99311.99311.99316.25320.35339.93
Other Intangible Assets
174.4179.02188.05194.13204.22220.55
Long-Term Deferred Tax Assets
29.1829.4827.6220.1710.9212.11
Long-Term Deferred Charges
40.448.5238.4219.1619.8815.67
Other Long-Term Assets
83.4670.9473.0377.5678.5785.6
Total Assets
1,5881,6431,5481,4331,5841,527
Accounts Payable
65.0262.8352.6236.7940.8947.35
Accrued Expenses
11.9945.9844.4650.6854.2757.01
Short-Term Debt
117.92115.41127.9467.4357.6791.03
Current Portion of Long-Term Debt
178.5539.42137.06-33.8493.73
Current Portion of Leases
-8.248.3-1.95.85
Current Income Taxes Payable
18.410.689.511.974.653.58
Current Unearned Revenue
37.5141.1825.9522.9538.2322.95
Other Current Liabilities
143.02293.45164.95242.54368.2378.53
Total Current Liabilities
572.41617.21570.81422.37599.68400.03
Long-Term Debt
257.75216153.3139.9174.5233.04
Long-Term Leases
17.522.6430.3218.8920.995.94
Long-Term Unearned Revenue
16.7416.9517.4315.3215.3816.16
Long-Term Deferred Tax Liabilities
42.3742.9444.4447.4940.5340.99
Other Long-Term Liabilities
167.58132.53133.2410.683.61286.07
Total Liabilities
1,0741,048949.55654.64854.7782.23
Common Stock
256.06256.11248.32241.62241.62227.97
Additional Paid-In Capital
441.62309.56349.58623.91623.91533.47
Retained Earnings
-195.01-198.36-223.21-265.4-290.59-172.03
Treasury Stock
-62.41-62.69-31.69---
Total Common Equity
440.25304.62343600.13574.94589.41
Minority Interest
73.82289.7255.18178.3154.77155.17
Shareholders' Equity
514.07594.33598.18778.43729.71744.58
Total Liabilities & Equity
1,5881,6431,5481,4331,5841,527
Total Debt
571.71401.72456.92226.22288.92229.59
Net Cash (Debt)
-434.1-240.4-307.41-94.21-24.97-122.33
Net Cash Per Share
-1.77-0.98-1.27-0.39-0.11-0.54
Filing Date Shares Outstanding
256.06256.11248.32241.62241.62227.97
Total Common Shares Outstanding
256.06256.11248.32241.62241.62227.97
Working Capital
-8.77-13.15-69.94-15.82-91.65-24.14
Book Value Per Share
1.721.191.382.482.382.59
Tangible Book Value
-46.14-186.39-157.0489.7550.3628.93
Tangible Book Value Per Share
-0.18-0.73-0.630.370.210.13
Buildings
-185.53210.74217.38230.56231.09
Machinery
-365.09359347.77384.06357.17
Construction In Progress
-23.6815.286.6444.673.93